Opinion|Videos|October 11, 2023
Patient Profile 1: A 70-Year-Old With Multiple Myeloma
The expert panel presents the patient case of a 70-year-old man with multiple myeloma and discusses treatment decisions.
Advertisement
Episodes in this series
Advertisement
Related to this article
Hematologic specialists discussed where ciltacabtagene autoleucel fits in the treatment paradigm at first relapse and beyond in multiple myeloma.
Updated NCCN Guidelines for multiple myeloma add a dedicated MRD testing framework and expand recommended MRD assessment timepoints.
Experts discussed whether CAR T cells or bispecific antibodies should be used first in relapsed/refractory multiple myeloma at the 2026 SOHO Annual Meeting.